Tenax Therapeutics (TENX) Amortization of Deferred Charges (2022)

Tenax Therapeutics (TENX) reported Amortization of Deferred Charges of $27857.0 for Q4 2022.

Tenax Therapeutics (TENX) Amortization of Deferred Charges (2022) Analysis & Trends

Tenax Therapeutics (TENX) has 1 years of Amortization of Deferred Charges data on file, last reported at $27857.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Tenax Therapeutics	67,856.40	67,856.40	-

Download Data

Date	Value
Dec 31, 2022	27,857.00
Dec 31, 2022	27,857.00